These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34339675)

  • 21. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.
    Zhang K; Zhuo H; Guo J; Wang W; Dai R
    Int Heart J; 2024; 65(1):119-127. PubMed ID: 38296564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac-specific BACH1 ablation attenuates pathological cardiac hypertrophy by inhibiting the Ang II type 1 receptor expression and the Ca2+/CaMKII pathway.
    Wei X; Jin J; Wu J; He Y; Guo J; Yang Z; Chen L; Hu K; Li L; Jia M; Li Q; Lv X; Ge F; Ma S; Wu H; Zhi X; Wang X; Jiang L; Osto E; Zhang J; Meng D
    Cardiovasc Res; 2023 Aug; 119(9):1842-1855. PubMed ID: 37279500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-181a mediates Ang II-induced myocardial hypertrophy by mediating autophagy.
    Li AL; Lv JB; Gao L
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(23):5462-5470. PubMed ID: 29243791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of p300-targeted acetylated residues in GATA4 during hypertrophic responses in cardiac myocytes.
    Takaya T; Kawamura T; Morimoto T; Ono K; Kita T; Shimatsu A; Hasegawa K
    J Biol Chem; 2008 Apr; 283(15):9828-35. PubMed ID: 18252717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TIR/BB-loop mimetic AS-1 prevents Ang II-induced hypertensive cardiac hypertrophy via NF-κB dependent downregulation of miRNA-143.
    Song J; Xie Q; Wang L; Lu Y; Liu P; Yang P; Chen R; Shao C; Qiao C; Wang Z; Yan J
    Sci Rep; 2019 Apr; 9(1):6354. PubMed ID: 31015570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nrf2 deficiency aggravates Angiotensin II-induced cardiac injury by increasing hypertrophy and enhancing IL-6/STAT3-dependent inflammation.
    Chen D; Li Z; Bao P; Chen M; Zhang M; Yan F; Xu Y; Ji C; Hu X; Sanchis D; Zhang Y; Ye J
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1253-1264. PubMed ID: 30668979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
    PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C1QTNF1 attenuates angiotensin II-induced cardiac hypertrophy via activation of the AMPKa pathway.
    Wu L; Gao L; Zhang D; Yao R; Huang Z; Du B; Wang Z; Xiao L; Li P; Li Y; Liang C; Zhang Y
    Free Radic Biol Med; 2018 Jun; 121():215-230. PubMed ID: 29733904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRT6 suppresses phenylephrine-induced cardiomyocyte hypertrophy though inhibiting p300.
    Shen P; Feng X; Zhang X; Huang X; Liu S; Lu X; Li J; You J; Lu J; Li Z; Ye J; Liu P
    J Pharmacol Sci; 2016 Sep; 132(1):31-40. PubMed ID: 27094368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteocrin alleviates cardiac hypertrophy via attenuating oxidative stress.
    Ji M; Zuo Z; Zhang M; Xu Z; Hu G
    Peptides; 2022 Jun; 152():170773. PubMed ID: 35218795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β-Activated Kinase 1-Dependent Signaling Pathways.
    Chen L; Huang J; Ji YX; Mei F; Wang PX; Deng KQ; Jiang X; Ma G; Li H
    Hypertension; 2017 Feb; 69(2):249-258. PubMed ID: 27956576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes.
    Jesus ICG; Scalzo S; Alves F; Marques K; Rocha-Resende C; Bader M; Santos RAS; Guatimosim S
    Am J Physiol Cell Physiol; 2018 Jun; 314(6):C702-C711. PubMed ID: 29443552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-30e-5p is sponged by Kcnq1ot1 and represses Angiotensin II-induced hypertrophic phenotypes in cardiomyocytes by targeting ADAM9.
    Wang W; Wu C; Ren L; Bao Y; Han Y; Li C; Li Y
    Exp Cell Res; 2020 Sep; 394(2):112140. PubMed ID: 32535037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caveolin-3 Overexpression Attenuates Cardiac Hypertrophy via Inhibition of T-type Ca2+ Current Modulated by Protein Kinase Cα in Cardiomyocytes.
    Markandeya YS; Phelan LJ; Woon MT; Keefe AM; Reynolds CR; August BK; Hacker TA; Roth DM; Patel HH; Balijepalli RC
    J Biol Chem; 2015 Sep; 290(36):22085-100. PubMed ID: 26170457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium butyrate attenuates angiotensin II-induced cardiac hypertrophy by inhibiting COX2/PGE2 pathway via a HDAC5/HDAC6-dependent mechanism.
    Zhang L; Deng M; Lu A; Chen Y; Chen Y; Wu C; Tan Z; Boini KM; Yang T; Zhu Q; Wang L
    J Cell Mol Med; 2019 Dec; 23(12):8139-8150. PubMed ID: 31565858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
    Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMNAT3 is involved in the protective effect of SIRT3 in Ang II-induced cardiac hypertrophy.
    Yue Z; Ma Y; You J; Li Z; Ding Y; He P; Lu X; Jiang J; Chen S; Liu P
    Exp Cell Res; 2016 Oct; 347(2):261-73. PubMed ID: 27423420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of endostatin overexpression on angiotensin II-induced cardiac hypertrophy in rats.
    Dai YJ; Gong JX; Bian R
    Chin Med J (Engl); 2019 Nov; 132(22):2716-2723. PubMed ID: 31725448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.